A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk (Q31049602)

17 August 2017

0 references

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk (English)

1 reference

17 August 2017

16

1 reference

28 June 2017

27

Loic Le Marchand

0 references

María-Dolores Chirlaque

10

Maria-Dolores Chirlaque

1 reference

17 August 2017

Bas Bueno-de-Mesquita

7

H B As Bueno-de-Mesquita

1 reference

17 August 2017

5

Demetrius Albanes

1 reference

17 August 2017

Alison J Price

37

0 references

Tatsuhiko Kubo

Tatsuhiko Kubo

26

0 references

Mathilde Touvier

Mathilde Touvier

46

0 references

Pilar Galan

Pilar Galan

15

0 references

Joan K Morris

Joan K Morris

30

0 references

Gianluca Severi

Gianluca Severi

41

0 references

Domenico Palli

Domenico Palli

34

0 references

Rudolf Kaaks

25

Rudolf Kaaks

1 reference

17 August 2017

Serge Hercberg

22

0 references

Mélanie Deschasaux

12

Mélanie Deschasaux

1 reference

17 August 2017

Richard M Martin

3

0 references

Luigi Ferrucci

14

Luigi Ferrucci

1 reference

17 August 2017

31

David E Neal

1 reference

17 August 2017

42

Meir J Stampfer

1 reference

17 August 2017

1

Ruth C Travis

1 reference

17 August 2017

17

Edward L Giovannucci

1 reference

17 August 2017

2

Paul N Appleby

1 reference

17 August 2017

32

Marian L Neuhouser

1 reference

17 August 2017

35

Elizabeth A Platz

1 reference

17 August 2017

40

Jeannette M Schenk

1 reference

17 August 2017

49

Regina G Ziegler

1 reference

17 August 2017

48

Noel S Weiss

1 reference

17 August 2017

44

Akiko Tamakoshi

1 reference

17 August 2017

33

Kotaro Ozasa

1 reference

17 August 2017

43

Pär Stattin

1 reference

17 August 2017

21

Kathy J Helzlsouer

1 reference

17 August 2017

19

Laurel A Habel

1 reference

17 August 2017

29

Kazuya Mikami

1 reference

17 August 2017

8

June M Chan

1 reference

17 August 2017

13

Jenny L Donovan

1 reference

17 August 2017

18

Marc J Gunter

1 reference

17 August 2017

20

Freddie C Hamdy

1 reference

17 August 2017

28

E Jeffrey Metter

1 reference

17 August 2017

39

Catherine Schaefer

1 reference

17 August 2017

45

Catherine M Tangen

1 reference

17 August 2017

38

Monique J Roobol

1 reference

17 August 2017

50

Timothy J Key

1 reference

17 August 2017

23

Robert N Hoover

1 reference

17 August 2017

6

Amanda Black

1 reference

17 August 2017

Jeff M P Holly

4

1 reference

17 August 2017

Chu Chen

9

1 reference

17 August 2017

Michael B Cook

11

1 reference

17 August 2017

Joseph A M J L Janssen

24

1 reference

17 August 2017

Nicholas J Wald

47

1 reference

17 August 2017

Naomi E Allen

51

1 reference

17 August 2017

Michael Pollak

36

1 reference

17 August 2017

language of work or name

English

0 references

publication date

26 February 2016

1 reference

17 August 2017

1 reference

17 August 2017

76

1 reference

17 August 2017

2288-2300

1 reference

17 August 2017

8

1 reference

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Illustrating bias due to conditioning on a collider

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Perspectives in mammalian IGFBP-3 biology: local vs. systemic action

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

IGF-binding protein-2 protects against the development of obesity and insulin resistance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Mechanisms by which IGF-I may promote cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factors and their binding proteins: biological actions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Prostate Cancer

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States).

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Fasting glucose is a risk factor for breast cancer: a prospective study.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Insulin-like growth factors and risk of benign prostatic hyperplasia.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873385

The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (Prostate testing for cancer and Treatment) study

25 November 2018

1 reference

12 December 2020

Relationship between serum levels of insulin-like growth factors and subsequent risk of cancer mortality: findings from a nested case-control study within the Japan Collaborative Cohort Study

1 reference

12 December 2020

Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer

1 reference

12 December 2020

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

1 reference

12 December 2020

Null association between insulin-like growth factors, insulin-like growth factor-binding proteins, and prostate cancer in a prospective study

1 reference

12 December 2020

Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening

1 reference

12 December 2020

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin

1 reference

12 December 2020

Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study

1 reference

12 December 2020

Lead-time in the European Randomised Study of Screening for Prostate Cancer

1 reference

12 December 2020

10.1158/0008-5472.CAN-15-1551

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

1 reference